Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.10 - Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC
12:05 - 12:10 | Presenter: Jonathan Wade Goldman | Author(s): E. Angevin, J. Strickler, D. Ross Camidge, R. Heist, D. Morgensztern, M. Barve, H. Yue, J. Beaulieu, M. Motwani, D. Afar, L. Naumovski, Karen Kelly
- Abstract
Loading...
-
+
MA 03 - Chemotherapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 502
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Jin-Hyoung Kang, W. Su
-
+
MA 03.01 - Nab-Paclitaxel ± CC-486 as Second-Line Treatment of Advanced NSCLC: Results from the ABOUND.2L+ Study
11:00 - 11:05 | Presenter: Ramaswamy Govindan | Author(s): D. Morgensztern, Manuel Cobo Dols, S. Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, J.R. Fischer, O.J. Vidal, D.J. Stewart, G. Fasola, J. Weaver, M. Wolfsteiner, T.J. Ong
- Abstract
Loading...
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-013 - ElevatION:NSCLC-101 – A Phase 1b Study of PDR001 Combined with Chemotherapy in PD-L1 Unselected, Metastatic NSCLC Patients
09:30 - 09:30 | Presenter: Enriqueta Felip | Author(s): Johan F. Vansteenkiste, Frances A Shepherd, Luis Paz-Ares, Fabrice Barlesi, S. Burgers, C. Cai, F. Kiertsman, J. Scott, T. McCulloch, Y.Y. Lau, D. Morgensztern
- Abstract
Loading...
-
+
MA 10 - Immunotherapy I
- 11:00 - 12:30
- 10/17/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:S. Wang, Robert Pirker
-
+
MA 10.02 - Nab-Paclitaxel + Durvalumab as Second- or Third-Line Treatment of Advanced NSCLC: Results from ABOUND.2L+
11:05 - 11:10 | Presenter: Ramaswamy Govindan | Author(s): Manuel Cobo Dols, S.P. Aix, Pieter E. Postmus, C. Lewanski, Jaafar Bennouna, J.R. Fischer, O.J. Vidal, David James Stewart, A. Ardizoni, J. Weaver, M. Wolfsteiner, Martin Reck, D. Talbot, D. Morgensztern, T.J. Ong
- Abstract
Loading...